Balancing the basal ganglia circuitry: A possible new role for dopamine D2 receptors in health and disease

Movement Disorders

Volumn 30, Issue 7, 2015, Pages 895-903

  Cazorla, Maxime ^a,b,c,d   Kang, Un Jung ^b   Kellendonk, Christoph ^a,b,c  

^a Department of Medicine   (United States)

^b New York State Psychiatric Institute ^*  (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d UNIV GRENOBLE ALPES   (France)

Author keywords

Bridging collaterals; Direct and indirect pathways; Dopamine receptors; Dyskinesia; Parkinson's disease

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HALOPERIDOL;

ADULTHOOD; ANATOMIC MODEL; ARTICLE; BASAL GANGLION; BEHAVIORAL SCIENCE; BRAIN DEVELOPMENT; BRAIN FUNCTION; DISEASES; HEALTH; HUMAN; LOCOMOTION; MOLECULAR PATHOLOGY; MOLECULARLY TARGETED THERAPY; MOTOR COORDINATION; NERVE CELL PLASTICITY; NERVE EXCITABILITY; NEUROANATOMY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; TARDIVE DYSKINESIA; TRANSLATIONAL RESEARCH; ANIMAL; BASAL GANGLIA DISEASES; NERVE CELL NETWORK; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BASAL GANGLIA; BASAL GANGLIA DISEASES; HUMANS; NERVE NET; RECEPTORS, DOPAMINE D2;

EID: 84931957048     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26282     Document Type: Article

References (56)

1. Albin RL, Young AB, Penny JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
2. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci 1990;13:244-254.
3. Gerfen CR, Engber TM, Mahan LC, et al. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science 1990;250:1429-1432.
4. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
5. Kawaguchi Y, Wilson CJ, Emson PC. Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin. J Neurosci 1990;10:3421-3438.
6. Wu Y, Richard S, Parent A. The organization of the striatal output system: a single-cell juxtacellular labeling study in the rat. Neurosci Res 2000;38:49-62.
7. Fujiyama F, Sohn J, Nakano T, et al. Exclusive and common targets of neostriatofugal projections of rat striosome neurons: a single neuron-tracing study using a viral vector. Eur J Neurosci 2011;33:668-677.
8. Levesque M, Parent A. The striatofugal fiber system in primates: a reevaluation of its organization based on single-axon tracing studies. Proc Natl Acad Sci U S A 2005;102:11888-11893.
9. Nadjar A, Brotchie JM, Guigoni C, et al. Phenotype of striatofugal medium spiny neurons in parkinsonian and dyskinetic nonhuman primates: a call for a reappraisal of the functional organization of the basal ganglia. J Neurosci 2006;26:8653-8661.
10. Parent A, Charara A, Pinault D. Single striatofugal axons arborizing in both pallidal segments and in the substantia nigra in primates. Brain Res 1995;698:280-284.
11. Cui G, Jun SB, Jin X, et al. Concurrent activation of striatal direct and indirect pathways during action initiation. Nature 2013;494:238-242.
12. Cazorla M, de Carvalho FD, Chohan MO, et al. Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. Neuron 2014;81:153-164.
13. Kravitz AV, Freeze BS, Parker PR, et al. Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature 2010;466:622-626.
14. Valjent E, Bertran-Gonzalez J, Herve D, Fisone G, Girault JA. Looking BAC at striatal signaling: cell-specific analysis in new transgenic mice. Trends Neurosci 2009;32:538-547.
15. Gerfen CR, Surmeier DJ. Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 2011;34:441-466.
16. Mallet N, Micklem BR, Henny P, et al. Dichotomous organization of the external globus pallidus. Neuron 2012;74:1075-1086.
17. Gittis AH, Berke JD, Bevan MD, et al. New roles for the external globus pallidus in basal ganglia circuits and behavior. J Neurosci 2014;34:15178-15183.
18. Mastro KJ, Bouchard RS, Holt HA, Gittis AH. Transgenic mouse lines subdivide external segment of the globus pallidus (GPe) neurons and reveal distinct GPe output pathways. J Neurosci 2014;34:2087-2099.
19. Bevan MD, Booth PA, Eaton SA, Bolam JP. Selective innervation of neostriatal interneurons by a subclass of neuron in the globus pallidus of the rat. J Neurosci 1998;18:9438-9452.
20. Chuhma N, Tanaka KF, Hen R, Rayport S. Functional connectome of the striatal medium spiny neuron. J Neurosci 2011;31:1183-1192.
21. Lalchandani RR, van der Goes MS, Partridge JG, Vicini S. Dopamine D2 receptors regulate collateral inhibition between striatal medium spiny neurons. J Neurosci 2013;33:14075-14086.
22. Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev 2000;80:953-978.
23. Mink JW. The Basal Ganglia and involuntary movements: impaired inhibition of competing motor patterns. Arch Neurol 2003;60:1365-1368.
24. Nambu A. Seven problems on the basal ganglia. Curr Opin Neurobiol 2008;18:595-604.
25. Durieux PF, Bearzatto B, Guiducci S, et al. D2R striatopallidal neurons inhibit both locomotor and drug reward processes. Nat Neurosci 2009;12:393-395.
26. Hikida T, Kimura K, Wada N, Funabiki K, Nakanishi S. Distinct roles of synaptic transmission in direct and indirect striatal pathways to reward and aversive behavior. Neuron 2010;66:896-907.
27. Kravitz AV, Tye LD, Kreitzer AC. Distinct roles for direct and indirect pathway striatal neurons in reinforcement. Nat Neurosci 2012;15:816-818.
28. Lobo MK, Covington HE, 3rd, Chaudhury D, et al. Cell type-specific loss of BDNF signaling mimics optogenetic control of cocaine reward. Science 2010;330:385-390.
29. Tai LH, Lee AM, Benavidez N, Bonci A, Wilbrecht L. Transient stimulation of distinct subpopulations of striatal neurons mimics changes in action value. Nat Neurosci 2012;15:1281-1289.
30. Maia TV, Frank MJ. From reinforcement learning models to psychiatric and neurological disorders. Nat Neurosci 2011;14:154-162.
31. Freeze BS, Kravitz AV, Hammack N, Berke JD, Kreitzer AC. Control of basal ganglia output by direct and indirect pathway projection neurons. J Neurosci 2013;33:18531-18539.
32. Catalano SM, Shatz CJ. Activity-dependent cortical target selection by thalamic axons. Science 1998;281:559-562.
33. De Marco Garcia NV, Karayannis T, Fishell G. Neuronal activity is required for the development of specific cortical interneuron subtypes. Nature 2011;472:351-355.
34. Hua JY, Smear MC, Baier H, Smith SJ. Regulation of axon growth in vivo by activity-based competition. Nature 2005;434:1022-1026.
35. Cazorla M, Shegda M, Ramesh B, Harrison NL, Kellendonk C. Striatal D2 receptors regulate dendritic morphology of medium spiny neurons via Kir2 channels. J Neurosci 2012;32:2398-2409.
36. Wilson CJ, Kawaguchi Y. The origins of two-state spontaneous membrane potential fluctuations of neostriatal spiny neurons. J Neurosci 1996;16:2397-2410.
37. McNeill TH, Brown SA, Rafols JA, Shoulson I. Atrophy of medium spiny I striatal dendrites in advanced Parkinson's disease. Brain Res 1988;455:148-152.
38. Tseng KY, Kasanetz F, Kargieman L, Riquelme LA, Murer MG. Cortical slow oscillatory activity is reflected in the membrane potential and spike trains of striatal neurons in rats with chronic nigrostriatal lesions. J Neurosci 2001;21:6430-6439.
39. Zaja-Milatovic S, Milatovic D, Schantz AM, et al. Dendritic degeneration in neostriatal medium spiny neurons in Parkinson disease. Neurology 2005;64:545-547.
40. Shen W, Tian X, Day M, et al. Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. Nat Neurosci 2007;10:1458-1466.
41. Azdad K, Chavez M, Don Bischop P, et al. Homeostatic plasticity of striatal neurons intrinsic excitability following dopamine depletion. PLoS One 2009;4:e6908.
42. Day M, Wang Z, Ding J, et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006;9:251-259.
43. Fieblinger T, Graves SM, Sebel LE, et al. Cell type-specific plasticity of striatal projection neurons in parkinsonism and L-DOPA-induced dyskinesia. Nat Commun 2014;5:5316.
44. Fino E, Glowinski J, Venance L. Effects of acute dopamine depletion on the electrophysiological properties of striatal neurons. Neurosci Res 2007;58:305-316.
45. Bevan MD, Magill PJ, Terman D, Bolam JP, Wilson CJ. Move to the rhythm: oscillations in the subthalamic nucleus-external globus pallidus network. Trends Neurosci 2002;25:525-531.
46. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994;72:507-520.
47. Best J, Park C, Terman D, Wilson C. Transitions between irregular and rhythmic firing patterns in excitatory-inhibitory neuronal networks. J Comput Neurosci 2007;23:217-235.
48. Dejean C, Arbuthnott G, Wickens JR, Le Moine C, Boraud T, Hyland BI. Power fluctuations in beta and gamma frequencies in rat globus pallidus:association with specific phases of slow oscillations and differential modulation by dopamine D1 and D2 receptors. J Neurosci 2011;31:6098-6107.
49. Howes OD, Kambeitz J, Kim E, et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 2012;69:776-786.
50. Abi-Dargham A, Rodenhiser J, Printz D, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci U S A 2000;97:8104-8109.
51. Meyer-Lindenberg A, Miletich RS, Kohn PD, et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 2002;5:267-271.
52. Abi-Dargham A, van de Giessen E, Slifstein M, Kegeles LS, Laruelle M. Baseline and amphetamine-stimulated dopamine activity are related in drug-naive schizophrenic subjects. Biol Psychiatry 2009;65:1091-1093.
53. Kumakura Y, Cumming P, Vernaleken I, et al. Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia:an [18F]fluorodopa/positron emission tomography study. J Neurosci 2007;27:8080-8087.
54. Howes OD, Montgomery AJ, Asselin MC, et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Arch Gen Psychiatry 2009;66:13-20.
55. Sherwood M, Thornton AE, Honer WG. A meta-analysis of profile and time-course of symptom change in acute schizophrenia treated with atypical antipsychotics. Int J Neuropsychopharmacol 2006;9:357-366.
56. Remington G. Tardive dyskinesia:eliminated, forgotten, or overshadowed? Curr Opin Psychiatry 2007;20:131-137.